Offer - Urjas Oil for just ₹ 1 X
Carca 6.25 Tablet (15) is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of High BP. The alternative uses of Carca 6.25 Tablet (15) have also been explained below.
The right dosage of Carca 6.25 Tablet (15) depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Carca 6.25 Tablet (15) as well, which are listed below. Usually, these side effects of Carca 6.25 Tablet (15) go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Carca 6.25 Tablet (15)'s effect is Moderate during pregnancy and Safe for lactating mothers. Warnings related to Carca 6.25 Tablet (15)'s effects on the liver, heart and kidney, if any, have been listed below.
Carca 6.25 Tablet (15) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Carca 6.25 Tablet (15) in conditions like Diabetes, Bradycardia (Slow Heart Rate), Peripheral Vascular Disease (PVD). The section on Carca 6.25 Tablet (15) contraindications lists all such conditions.
Drug interactions for Carca 6.25 Tablet (15) have been reported in the medical literature. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Carca 6.25 Tablet (15) is considered not safe while driving, and is not addictive.
Carca 6.25 Tablet (15) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Carca 6.25 Tablet (15) safe for pregnant women?
Carca can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Carca right away. Take your doctor's advice before taking it again.
Is the use of Carca 6.25 Tablet (15) safe during breastfeeding?
Carca is completely safe for breastfeeding women.
What is the effect of Carca 6.25 Tablet (15) on the Kidneys?
There are no side effects of Carca on the kidneys.
What is the effect of Carca 6.25 Tablet (15) on the Liver?
Carca has very mild side effects on the liver.
What is the effect of Carca 6.25 Tablet (15) on the Heart?
Carca is rarely harmful for the heart.
Carca 6.25 Tablet (15) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Carca 6.25 Tablet (15) unless your doctor advises you to do so -
Is this Carca 6.25 Tablet (15) habit forming or addictive?
Carca 6.25 Tablet (15) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Carca 6.25 Tablet (15) as you may feel sleepy.
Is it safe?
Carca 6.25 Tablet (15) should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Carca 6.25 Tablet (15) for mental disorders.
Interaction between Food and Carca 6.25 Tablet (15)
Eating certain foods may increase the time it takes Carca 6.25 Tablet (15) to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Carca 6.25 Tablet (15)
Consuming Carca 6.25 Tablet (15) with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 287-288
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 564
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg® (carvedilol)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg Cr® (carvedilol phosphate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Vedilol® (carvedilol)